Decision aid for medullary thyroid cancer treatment choices
Part of Cancer clinical trials.
This study tests a patient-and-caregiver decision guide to help you decide when to start or stop a new cancer drug, join a clinical trial, or continue active surveillance. It aims to make tough choices feel clearer and more supported.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older and have medullary thyroid cancer (or are a caregiver/family member of someone who does)
- You (or the person you care for) are facing a decision about starting/stopping new drugs, joining a trial, or active surveillance
- You can speak, read, and write in English
- You may be able to join even if you are pregnant
- You don’t have severe thinking or mental health problems that would stop you from using the decision guide (for example, severe mental illness)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a culturally tailored educational tool to help Hispanic or Latino/a patients with medullary thyroid cancer and their caregivers make informed decisions. It aims to improve understanding and support for Spanish-speaking individuals.
This study is testing a tool called TA-DA to help patients with advanced cancer and their caregivers make decisions about further treatment after at least two prior therapies. It aims to improve shared decision-making.
This trial tests an English decision aid (a patient guide) to help older men understand and feel comfortable with “active surveillance” for localized prostate cancer. It also checks how easy to use it is for patients, caregivers, and prostate cancer clinicians.
This study tests a decision aid to help men aged 65 and older with early-stage prostate cancer decide whether to choose active surveillance (monitoring the cancer instead of immediate treatment). The goal is to see if the tool helps men and their care partners make a more informed choice.
This study collects real-world information from patients with advanced thyroid cancer to better understand how standard treatments and specialized procedures work. Your participation will help improve care for others with this type of cancer.
This study tests a decision aid to help people with low-risk thyroid cancer or suspicious nodules make informed choices about their care. It may help you understand your options and feel more confident in your decisions.
Hear when a new Thyroid Gland Medullary Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.